121 related articles for article (PubMed ID: 10207635)
1. CYP2D6 genotype and the incidence of anal and vulvar cancer.
Chen C; Cook LS; Li XY; Hallagan S; Madeleine MM; Daling JR; Weiss NS
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):317-21. PubMed ID: 10207635
[TBL] [Abstract][Full Text] [Related]
2. Glutathione S-transferase M1 genotypes and the risk of anal cancer: a population-based case-control study.
Chen C; Madeleine MM; Lubinski C; Weiss NS; Tickman EW; Daling JR
Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):985-91. PubMed ID: 8959321
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism of CYP2D6 and lung cancer risk.
Shaw GL; Falk RT; Frame JN; Weiffenbach B; Nesbitt JC; Pass HI; Caporaso NE; Moir DT; Tucker MA
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):215-9. PubMed ID: 9521436
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer.
Park JY; Lee SY; Jeon HS; Bae NC; Chae SC; Joo S; Kim CH; Park JH; Kam S; Kim IS; Jung TH
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):23-7. PubMed ID: 11815397
[TBL] [Abstract][Full Text] [Related]
5. On the etiology of anal squamous carcinoma.
Frisch M
Dan Med Bull; 2002 Aug; 49(3):194-209. PubMed ID: 12238281
[TBL] [Abstract][Full Text] [Related]
6. Debrisoquine hydroxylase (CYP2D6) and prostate cancer.
Febbo PG; Kantoff PW; Giovannucci E; Brown M; Chang G; Hennekens CH; Stampfer M
Cancer Epidemiol Biomarkers Prev; 1998 Dec; 7(12):1075-8. PubMed ID: 9865424
[TBL] [Abstract][Full Text] [Related]
7. Correspondence re: C. Chen et al., CYP2D6 genotype and the incidence of anal and vulvar cancer. Cancer Epidemiol. Biomark. Prev., 8: 317-321, 1999.
Hecht SS
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):839-40. PubMed ID: 10498405
[No Abstract] [Full Text] [Related]
8. Point: myeloperoxidase -463G --> a polymorphism and lung cancer risk.
Feyler A; Voho A; Bouchardy C; Kuokkanen K; Dayer P; Hirvonen A; Benhamou S
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1550-4. PubMed ID: 12496042
[TBL] [Abstract][Full Text] [Related]
9. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
[TBL] [Abstract][Full Text] [Related]
10. Effects of CYP2D6 activity and tobacco on larynx cancer risk.
Benhamou S; Bouchardy C; Paoletti C; Dayer P
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):683-6. PubMed ID: 8877058
[TBL] [Abstract][Full Text] [Related]
11. The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer.
Zhou W; Thurston SW; Liu G; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):461-6. PubMed ID: 11352855
[TBL] [Abstract][Full Text] [Related]
12. The role of CYP2D6*4 variant in bladder cancer susceptibility in Tunisian patients.
Ouerhani S; Marrakchi R; Bouhaha R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; El Gaaied AB
Bull Cancer; 2008 Feb; 95(2):E1-4. PubMed ID: 18304900
[TBL] [Abstract][Full Text] [Related]
13. Alcohol dehydrogenase 3 genotype is not associated with risk of squamous cell carcinoma of the oral cavity and pharynx.
Sturgis EM; Dahlstrom KR; Guan Y; Eicher SA; Strom SS; Spitz MR; Wei Q
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):273-5. PubMed ID: 11303599
[TBL] [Abstract][Full Text] [Related]
14. Nicotine metabolism and CYP2D6 phenotype in smokers.
Caporaso NE; Lerman C; Audrain J; Boyd NR; Main D; Issaq HJ; Utermahlan B; Falk RT; Shields P
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):261-3. PubMed ID: 11303596
[TBL] [Abstract][Full Text] [Related]
15. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
[TBL] [Abstract][Full Text] [Related]
16. The effect of tobacco on lung cancer risk depends on CYP2D6 activity.
Bouchardy C; Benhamou S; Dayer P
Cancer Res; 1996 Jan; 56(2):251-3. PubMed ID: 8542575
[TBL] [Abstract][Full Text] [Related]
17. CYP1A2 genetic polymorphisms and adenocarcinoma lung cancer risk in the Tunisian population.
B'chir F; Pavanello S; Knani J; Boughattas S; Arnaud MJ; Saguem S
Life Sci; 2009 May; 84(21-22):779-84. PubMed ID: 19332078
[TBL] [Abstract][Full Text] [Related]
18. Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study.
Chin-Hong PV; Vittinghoff E; Cranston RD; Browne L; Buchbinder S; Colfax G; Da Costa M; Darragh T; Benet DJ; Judson F; Koblin B; Mayer KH; Palefsky JM
J Natl Cancer Inst; 2005 Jun; 97(12):896-905. PubMed ID: 15956651
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population.
Griese EU; Asante-Poku S; Ofori-Adjei D; Mikus G; Eichelbaum M
Pharmacogenetics; 1999 Dec; 9(6):715-23. PubMed ID: 10634134
[TBL] [Abstract][Full Text] [Related]
20. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer.
Daling JR; Weiss NS; Hislop TG; Maden C; Coates RJ; Sherman KJ; Ashley RL; Beagrie M; Ryan JA; Corey L
N Engl J Med; 1987 Oct; 317(16):973-7. PubMed ID: 2821396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
